3,4-Dichlorobenzotrifluoride Pharmaceutical Grade

Pharmaceutical-grade 3,4-Dichlorobenzotrifluoride with <10ppm heavy metals, used in synthesis of anti-cancer drug intermediates. Meets HTS 2903.99.08.00 as explicitly named halogenated aromatic hydrocarbon under chapter 29 pure compound provisions.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳China5.5%+10.0%15.5%
🇲🇽Mexico5.5%+10.0%15.5%
🇨🇦Canada5.5%+10.0%15.5%
🇩🇪Germany5.5%+10.0%15.5%
🇯🇵Japan5.5%+10.0%15.5%

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

2933.39.61Lower: 6.5% vs 15.5%

If converted to pyridine derivatives during processing

Nitrogen heterocycles from halogenated precursors classified in 2933, not parent hydrocarbons.

2942.00.10.00Higher: 41.5% vs 15.5%

If isolated as sugar ether derivative

Chapter notes specify sugar derivatives move to 2940 regardless of parent structure.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

Provide Certificate of Analysis (CoA) with ICH Q3D elemental impurities testing results

Declare under FDA prior notice if destined for US pharmaceutical manufacturing

Use EP/USP stabilizer-free packaging to maintain chapter 29 classification

Related Products under HTS 2903.99.08.00